View in EDS PDF Full Text

TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy.

Saved in:
Bibliographic Details
Title: TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy.
Authors: McNerney KO; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Karageorgos S; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Ferry GM; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Wolpaw AJ; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; The Wistar Institute, Philadelphia, PA., Burudpakdee C; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Khurana P; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Toland CN; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Vemu R; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Vu A; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Hogarty MD; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Bassiri H; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Source: Oncoimmunology [Oncoimmunology] 2022 May 24; Vol. 11 (1), pp. 2075204. Date of Electronic Publication: 2022 May 24 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35646475
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22McNerney+KO%22">McNerney KO</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Karageorgos+S%22">Karageorgos S</searchLink>; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ferry+GM%22">Ferry GM</searchLink>; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Wolpaw+AJ%22">Wolpaw AJ</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; The Wistar Institute, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Burudpakdee+C%22">Burudpakdee C</searchLink>; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Khurana+P%22">Khurana P</searchLink>; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Toland+CN%22">Toland CN</searchLink>; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Vemu+R%22">Vemu R</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Vu+A%22">Vu A</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Hogarty+MD%22">Hogarty MD</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Bassiri+H%22">Bassiri H</searchLink>; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2022 May 24; Vol. 11 (1), pp. 2075204. <i>Date of Electronic Publication: </i>2022 May 24 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2162-402X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35646475
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2022.2075204
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2075204
    Titles:
      – TitleFull: TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McNerney KO
      – PersonEntity:
          Name:
            NameFull: Karageorgos S
      – PersonEntity:
          Name:
            NameFull: Ferry GM
      – PersonEntity:
          Name:
            NameFull: Wolpaw AJ
      – PersonEntity:
          Name:
            NameFull: Burudpakdee C
      – PersonEntity:
          Name:
            NameFull: Khurana P
      – PersonEntity:
          Name:
            NameFull: Toland CN
      – PersonEntity:
          Name:
            NameFull: Vemu R
      – PersonEntity:
          Name:
            NameFull: Vu A
      – PersonEntity:
          Name:
            NameFull: Hogarty MD
      – PersonEntity:
          Name:
            NameFull: Bassiri H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 05
              Text: 2022 May 24
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2162-402X
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1